{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:31:57Z","timestamp":1792981917897,"version":"4.5.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the Therapeutic effect of synchronous Integrated intensity modulated radiotherapy combined with chemotherapy in stage IIIc of Cervical Cancer<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 58 patients with stage IIIC cervical cancer (KPS \u2265 80) were analyzed in this study. They were admitted to our hospital between August 2017 and August 2022. Synchronous integrated boost intensity-modulated radiotherapy (SIB-IMRT) and sequential boost intensity-modulated radiotherapy (LCB-IMRT) were used to treat pelvic and\/or para-aortic metastatic lymph nodes, with 30 cases in the SIB group and 28 cases in the LCB group. Comparison of short-term and long-term efficacy. Comparison of recurrence and metastasis rates, radiation dose to organs at risk and incidence of adverse drug reactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>30 patients were treated with simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT), and 28 patients were treated with sequential boost intensity-modulated radiotherapy (LCB-IMRT). At the completion of radiotherapy and 3 months after radiotherapy, there was no significant difference in clinical efficacy observed between the two treatment groups. The median overall survival (OS), progression-free survival (PFS), and disease-free survival (DMR) in the SIB-IMRT group were significantly higher compared to the LCB-IMRT group. The SIB-IMRT group demonstrated significantly lower rates compared to the LCB-IMRT group. Furthermore, within 3 years and 5 years, the rates of lymph node recurrence, cervical and vaginal local recurrence, and distant metastasis within the radiotherapy field were significantly lower in the SIB-IMRT group compared to the LCB-IMRT group. There were no significant differences observed between the two groups in terms of the maximum dose to the small intestine (Dmax), dose received by 2cc of the small intestine (D2cc), maximum dose to the rectum (Dmax), and dose received by 1cc of the bladder (D1cc). The incidence of bone marrow toxicity in the SIB-IMRT group was significantly lower compared to the LCB-IMRT group. Moreover, the occurrence of grade III and IV bone marrow toxicity was also significantly lower in the SIB-IMRT group compared to the LCB-IMRT group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The study has concluded that there is no significant differences in in terms of bladder associated adverse events and gastrointestinal toxicity in both Simultaneous Integrated Boost Intensity-Modulated Radiotherapy and Layered Conical Beam Intensity-Modulated Radiation Therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1283991","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T06:00:41Z","timestamp":1717048841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of the therapeutic effect of synchronous integrated intensity modulated radiotherapy combined with chemotherapy in stage IIIc of cervical cancer"],"prefix":"10.3389","volume":"14","author":[{"given":"Yanru","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.13283\/j.cnki.xdfckjz.20140625.004","article-title":"Preliminary study on the value of MRI combined with transvaginal color Doppler ultrasound in evaluating the condition of early cervical cancer","volume":"23","author":"Gao","year":"2014","journal-title":"Mod Obstet Gynecol Prog"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-8179.2010.11.009","article-title":"The value of SCC-Ag in the evaluation of lymph node metastasis in patients with early cervical cancer","volume":"37","author":"Gao","year":"2010","journal-title":"Ther Effect Anal Synchr Comb Ther Cervical Cancer Stage IIIc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121385","article-title":"Volumetric modulated arc therapy vs. c-IMRT for the reatment of upper thoracic esophageal cancer","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1088\/0031-9155\/56\/5\/R01","article-title":"Intensity-modulated arc therapy: principles, technologies and clinical implementation","volume":"56","author":"Cedric","year":"2011","journal-title":"Phys Med Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2014.43156","article-title":"Feasibility of simultaneous integrated boost with forward intensity-modulated radiation therapy for multiple brain metastases","volume":"18","author":"Ni","year":"2014","journal-title":"Contemp Oncology\/Wsp\u00f3\u0142czesna Onkologia"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0254-5098.2018.06.004","article-title":"Dosimetry study of SPECT definition of active bone marrow to optimize postoperative intensity modulated radiotherapy planning for cervical cancer","volume":"38","author":"Huang","year":"2018","journal-title":"Chin J Radiat Med Protection"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-015-0698-5","article-title":"Pros and cons of adding of neoadjuvant chemotherapy to standard concurrent chemoradiotherapy in cervical cancer: a regional cancer center experience","volume":"66","author":"Narayan","year":"2016","journal-title":"J Obstetrics Gynecology India"},{"key":"B9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3969\/j.issn.1003-4706.2015.01.030","article-title":"clinical observation of synchronous intensity modulated radiotherapy in radiotherapy for official neck cancer","volume":"36","author":"Jiang","year":"2015","journal-title":"J Kunming Med Univ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.022","article-title":"Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer","volume":"83","author":"Goodman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e10","article-title":"Quality and quantity metrics of pelvic lymph node metastasis and risk of paraaortic lymph node metastasis in stage IB-IIB cervical cancer","volume":"29","author":"Matsuo","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000778","article-title":"The prognosis and risk stratification based on pelvic lymph node characteristics in patients with locally advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy","volume":"26","author":"Li","year":"2016","journal-title":"Int J Gynecologic Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of che - moradiotherapy for cervical cancer:a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology\u2013RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181e6f321","article-title":"Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix","volume":"20","author":"Forrest","year":"2010","journal-title":"Int J Gynecologic Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-5930.2013.01.024","article-title":"Curative effect of radical radiotherapy for pelvic lymph node metastasis of cervical cancer","volume":"28","author":"Li","year":"2013","journal-title":"J Pract Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3969\/i.issn.1672-1993.2020.05.007","article-title":"Clinical efficacy and toxicity of concurrent and late-course boost radiotherapy for pelvic and abdominal metastatic lymph nodes in intensity-modulated radiotherapy for cervical cancer","volume":"29","author":"Wu","year":"2020","journal-title":"Chin Sex Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-5930.2021.04.037","article-title":"Observation on the efficacy of late course reduced field plus intensity modulated radiotherapy in patients with advanced cervical cancer with lymph node \u2265 2cm","volume":"36","author":"Liu","year":"2021","journal-title":"J Pract Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000437052","article-title":"Hypertrophic osteoarthropathy and follicular thyroid cancer: a rare paraneoplastic syndrome","volume":"4","author":"Tavarelli","year":"2015","journal-title":"Eur Thyroid J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-015-0499-0","article-title":"Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer","volume":"10","author":"Whalley","year":"2015","journal-title":"Radiat Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01443615.2021.2012437","article-title":"The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis","volume":"5","author":"Zhong","year":"2022","journal-title":"J Obstet Gynaecol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1283991\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T06:00:58Z","timestamp":1717048858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1283991\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":21,"alternative-id":["10.3389\/fonc.2024.1283991"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1283991","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"article-number":"1283991"}}